# Safety Study of HBV-002 West Nile Vaccine in Healthy Adults

> **NCT00707642** · PHASE1 · COMPLETED · sponsor: **Hawaii Biotech, Inc.** · enrollment: 25 (actual)

## Conditions studied

- West Nile Virus Disease

## Interventions

- **BIOLOGICAL:** WN-80E
- **BIOLOGICAL:** WN-80E
- **BIOLOGICAL:** WN-80E
- **BIOLOGICAL:** WN-80E

## Key facts

- **NCT ID:** NCT00707642
- **Lead sponsor:** Hawaii Biotech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2009-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00707642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00707642, "Safety Study of HBV-002 West Nile Vaccine in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00707642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*